[Effects of antiandrogenic treatment with cyproterone acetate on the sexual tonus in virilized women].
Sexual responsiveness was assessed in 46 virilized women during cyproterone acetate treatment over a period of several years according to a sexual score previously described. In general, sexual tonus was depressed by intensive cyproterone acetate medication of several months' duration without concurrent oestrogen. By changing to sequential therapy according to Hammerstein, however, sexual tonus returned to initial levels in the group with normal pre-medication responsiveness. Furthermore, in another group with diminished sexual tonus before treatment, sexual responsiveness, in particular the capacity for orgasm, was stimulated to the level of the first group. The endocrinological basis for this observation is discussed with aid of results of the plasma testosterone/sex hormone binding globulin complex.
D000328:Adult; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008875:Middle Aged; D009948:Orgasm / Q000187:drug effects; D013739:Testosterone / Q000097:blood; D014770:Virilism / Q000188:drug therapy*
D013739:Testosterone; D017373:Cyproterone Acetate; D003534:Cyproterone
Einflüsse antiandrogener Behandlung mit Cyproteronazetat (CA) auf den Sexualtonus virilisierter Frauen.